
George A. Suchfield
Examiner (ID: 12000)
| Most Active Art Unit | 3506 |
| Art Unit(s) | 3676, 3672, 3506, 3625, 2899, 3674, 3504 |
| Total Applications | 3575 |
| Issued Applications | 3201 |
| Pending Applications | 150 |
| Abandoned Applications | 229 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18642419
[patent_doc_number] => 11766472
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Method of treatment for hair loss
[patent_app_type] => utility
[patent_app_number] => 17/207716
[patent_app_country] => US
[patent_app_date] => 2021-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 47
[patent_no_of_words] => 16754
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17207716
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/207716 | Method of treatment for hair loss | Mar 20, 2021 | Issued |
Array
(
[id] => 17420132
[patent_doc_number] => 11253561
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Nutritional composition
[patent_app_type] => utility
[patent_app_number] => 17/200056
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2541
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17200056
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/200056 | Nutritional composition | Mar 11, 2021 | Issued |
Array
(
[id] => 19273256
[patent_doc_number] => 12023363
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => Natural product compositions for treating or managing symptoms of ADD, ADHD, anxiety, and depression
[patent_app_type] => utility
[patent_app_number] => 17/191507
[patent_app_country] => US
[patent_app_date] => 2021-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17137
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17191507
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/191507 | Natural product compositions for treating or managing symptoms of ADD, ADHD, anxiety, and depression | Mar 2, 2021 | Issued |
Array
(
[id] => 18335551
[patent_doc_number] => 20230127499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => PEPTIDES AND ADJUVANTS FOR AUGMENTATION OF FIBROBLAST THERAPY FOR CORONAVIRUS
[patent_app_type] => utility
[patent_app_number] => 17/905961
[patent_app_country] => US
[patent_app_date] => 2021-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18243
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -75
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905961
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905961 | PEPTIDES AND ADJUVANTS FOR AUGMENTATION OF FIBROBLAST THERAPY FOR CORONAVIRUS | Mar 1, 2021 | Pending |
Array
(
[id] => 16913821
[patent_doc_number] => 20210186913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING THE EYE
[patent_app_type] => utility
[patent_app_number] => 17/189009
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17189009
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/189009 | Compositions and methods for treating the eye | Feb 28, 2021 | Issued |
Array
(
[id] => 17113235
[patent_doc_number] => 20210293832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => TEST STRIPS FOR DETERMINING COAGULATION FACTOR ACTIVITIES
[patent_app_type] => utility
[patent_app_number] => 17/187460
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7293
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17187460
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/187460 | Test strips for determining coagulation factor activities | Feb 25, 2021 | Issued |
Array
(
[id] => 18283418
[patent_doc_number] => 20230098890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => TREATMENT OF CEREBRAL PALSY USING FIBROBLASTS
[patent_app_type] => utility
[patent_app_number] => 17/760318
[patent_app_country] => US
[patent_app_date] => 2021-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10587
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17760318
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/760318 | Treatment of cerebral palsy using fibroblasts | Feb 11, 2021 | Issued |
Array
(
[id] => 17200486
[patent_doc_number] => 20210340581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => POLYHYDROXYALKANOIC ACID COMPOSITIONS AND METHODS FOR GENERATING SAME
[patent_app_type] => utility
[patent_app_number] => 17/171948
[patent_app_country] => US
[patent_app_date] => 2021-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8729
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17171948
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/171948 | POLYHYDROXYALKANOIC ACID COMPOSITIONS AND METHODS FOR GENERATING SAME | Feb 8, 2021 | Abandoned |
Array
(
[id] => 17065861
[patent_doc_number] => 20210268076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => Treatment of Diseases Related to Hyperactivity of the Complement System
[patent_app_type] => utility
[patent_app_number] => 17/171524
[patent_app_country] => US
[patent_app_date] => 2021-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8065
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17171524
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/171524 | Treatment of Diseases Related to Hyperactivity of the Complement System | Feb 8, 2021 | Abandoned |
Array
(
[id] => 19060410
[patent_doc_number] => 11939620
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Regulation of feed efficiency and methane production in ruminating animals
[patent_app_type] => utility
[patent_app_number] => 17/170937
[patent_app_country] => US
[patent_app_date] => 2021-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 70
[patent_no_of_words] => 23732
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17170937
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/170937 | Regulation of feed efficiency and methane production in ruminating animals | Feb 8, 2021 | Issued |
Array
(
[id] => 18762915
[patent_doc_number] => 11813294
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-14
[patent_title] => Methods for the treatment of autism spectrum disorders
[patent_app_type] => utility
[patent_app_number] => 17/170373
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 3
[patent_no_of_words] => 8521
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17170373
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/170373 | Methods for the treatment of autism spectrum disorders | Feb 7, 2021 | Issued |
Array
(
[id] => 17946045
[patent_doc_number] => 20220333062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => BIFIDOBACTERIUM BREVE 207-1 AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/762014
[patent_app_country] => US
[patent_app_date] => 2021-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7579
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17762014
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/762014 | None | Feb 1, 2021 | Issued |
Array
(
[id] => 16883748
[patent_doc_number] => 20210169943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS
[patent_app_type] => utility
[patent_app_number] => 17/157761
[patent_app_country] => US
[patent_app_date] => 2021-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18196
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17157761
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/157761 | USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS | Jan 24, 2021 | Abandoned |
Array
(
[id] => 17200465
[patent_doc_number] => 20210340560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => IMPROVED RECOMBINANT PROTEIN EXPRESSION USING A HYBRID CHEF1 PROMOTER
[patent_app_type] => utility
[patent_app_number] => 17/142971
[patent_app_country] => US
[patent_app_date] => 2021-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7324
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17142971
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/142971 | IMPROVED RECOMBINANT PROTEIN EXPRESSION USING A HYBRID CHEF1 PROMOTER | Jan 5, 2021 | Abandoned |
Array
(
[id] => 16805934
[patent_doc_number] => 20210128487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => NANO COMPLEX COMPRISING A NANO DRUG DELIVERY MATRIX; AND A GINSENG EXTRACT OR A GINSENOSIDE ISOLATED THEREFROM
[patent_app_type] => utility
[patent_app_number] => 17/142768
[patent_app_country] => US
[patent_app_date] => 2021-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17142768
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/142768 | Nano complex comprising a nano drug delivery matrix; and a | Jan 5, 2021 | Issued |
Array
(
[id] => 17050700
[patent_doc_number] => 20210260134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => Compositions and Methods for Tissue Repair with Extracellular Matrices
[patent_app_type] => utility
[patent_app_number] => 17/135785
[patent_app_country] => US
[patent_app_date] => 2020-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17135785
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/135785 | Compositions and methods for tissue repair with extracellular matrices | Dec 27, 2020 | Issued |
Array
(
[id] => 16776535
[patent_doc_number] => 20210113612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => Blood Plasma and Plasma Fractions as Therapy for Tumor Growth and Progression
[patent_app_type] => utility
[patent_app_number] => 17/132772
[patent_app_country] => US
[patent_app_date] => 2020-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13874
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17132772
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/132772 | Blood Plasma and Plasma Fractions as Therapy for Tumor Growth and Progression | Dec 22, 2020 | Abandoned |
Array
(
[id] => 18019006
[patent_doc_number] => 20220370505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => PREVENTION AND TREATMENT OF KIDNEY FAILURE BY ADMINISTRATION OF FIBROBLASTS AND PRODUCTS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/757309
[patent_app_country] => US
[patent_app_date] => 2020-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15303
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17757309
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/757309 | Prevention and treatment of kidney failure by administration of fibroblasts and products thereof | Dec 21, 2020 | Issued |
Array
(
[id] => 18461611
[patent_doc_number] => 11685895
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-27
[patent_title] => Method for manufacturing microalgae micro powder containing astaxanthin and fatty acids with enhanced penetration performance and food availability
[patent_app_type] => utility
[patent_app_number] => 17/120119
[patent_app_country] => US
[patent_app_date] => 2020-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12055
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17120119
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/120119 | Method for manufacturing microalgae micro powder containing astaxanthin and fatty acids with enhanced penetration performance and food availability | Dec 11, 2020 | Issued |
Array
(
[id] => 17226971
[patent_doc_number] => 20210353527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => COMPOSITION FOR STRENGTHENING SKIN BARRIER, MOISTURIZING SKIN OR ANTI-AGING
[patent_app_type] => utility
[patent_app_number] => 17/113744
[patent_app_country] => US
[patent_app_date] => 2020-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17113744
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/113744 | Composition for strengthening skin barrier, moisturizing skin or anti-aging | Dec 6, 2020 | Issued |